205 related articles for article (PubMed ID: 30251170)
41. Facilitating decision-making in women undergoing genetic testing for hereditary breast cancer: BRECONDA randomized controlled trial results.
Sherman KA; Kilby CJ; Shaw LK; Winch C; Kirk J; Tucker K; Elder E
Breast; 2017 Dec; 36():79-85. PubMed ID: 29031121
[TBL] [Abstract][Full Text] [Related]
42. Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.
Tsaousis GN; Papadopoulou E; Apessos A; Agiannitopoulos K; Pepe G; Kampouri S; Diamantopoulos N; Floros T; Iosifidou R; Katopodi O; Koumarianou A; Markopoulos C; Papazisis K; Venizelos V; Xanthakis I; Xepapadakis G; Banu E; Eniu DT; Negru S; Stanculeanu DL; Ungureanu A; Ozmen V; Tansan S; Tekinel M; Yalcin S; Nasioulas G
BMC Cancer; 2019 Jun; 19(1):535. PubMed ID: 31159747
[TBL] [Abstract][Full Text] [Related]
43. [Genetic predisposition to breast and ovarian cancer: importance of test results].
Julian-Reynier C
Med Sci (Paris); 2011; 27(6-7):657-61. PubMed ID: 21718651
[TBL] [Abstract][Full Text] [Related]
44. Effect on perceived control and psychological distress of genetic knowledge in women with breast cancer receiving a BRCA1/2 test result.
Brédart A; Kop JL; De Pauw A; Caron O; Fajac A; Noguès C; Stoppa-Lyonnet D; Dolbeault S
Breast; 2017 Feb; 31():121-127. PubMed ID: 27837705
[TBL] [Abstract][Full Text] [Related]
45. Knowledge and expectations of women undergoing cancer genetic risk assessment: a qualitative analysis of free-text questionnaire comments.
Phelps C; Wood F; Bennett P; Brain K; Gray J
J Genet Couns; 2007 Aug; 16(4):505-14. PubMed ID: 17318449
[TBL] [Abstract][Full Text] [Related]
46. Development and pilot testing of a decision aid for men considering genetic testing for breast and/or ovarian cancer-related mutations (BRCA1/2).
Juan AS; Wakefield CE; Kasparian NA; Kirk J; Tyler J; Tucker K
Genet Test; 2008 Dec; 12(4):523-32. PubMed ID: 19072564
[TBL] [Abstract][Full Text] [Related]
47. Making Sense of SNPs: Women's Understanding and Experiences of Receiving a Personalized Profile of Their Breast Cancer Risks.
Young MA; Forrest LE; Rasmussen VM; James P; Mitchell G; Sawyer SD; Reeve K; Hallowell N
J Genet Couns; 2018 Jun; 27(3):702-708. PubMed ID: 29168041
[TBL] [Abstract][Full Text] [Related]
48. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.
Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD
Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844
[TBL] [Abstract][Full Text] [Related]
49. Psychosocial aspects of cancer genetics: women at high risk for breast and ovarian cancer.
Kash KM; Ortega-Verdejo K; Dabney MK; Holland JC; Miller DG; Osborne MP
Semin Surg Oncol; 2000 Jun; 18(4):333-8. PubMed ID: 10805955
[TBL] [Abstract][Full Text] [Related]
50. Polygenic risk in familial breast cancer: Changing the dynamics of communicating genetic risk.
Gregory G; Das Gupta K; Meiser B; Barlow-Stewart K; Geelan-Small P; Kaur R; Scheepers-Joynt M; McInerny S; Taylor S; Antill Y; Salmon L; Smyth C; Young MA; James PA; Yanes T
J Genet Couns; 2022 Feb; 31(1):120-129. PubMed ID: 34223688
[TBL] [Abstract][Full Text] [Related]
51. Psychological distress in women seeking genetic counseling for breast-ovarian cancer risk: the contributions of personality and appraisal.
Audrain J; Schwartz MD; Lerman C; Hughes C; Peshkin BN; Biesecker B
Ann Behav Med; 1997; 19(4):370-7. PubMed ID: 9706364
[TBL] [Abstract][Full Text] [Related]
52. Education about genetic testing for breast cancer susceptibility: patient preferences for a computer program or genetic counselor.
Green MJ; McInerney AM; Biesecker BB; Fost N
Am J Med Genet; 2001 Sep; 103(1):24-31. PubMed ID: 11562930
[TBL] [Abstract][Full Text] [Related]
53. Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer.
Cappelli M; Surh L; Humphreys L; Verma S; Logan D; Hunter A; Allanson J
Clin Genet; 1999 Jun; 55(6):419-30. PubMed ID: 10450858
[TBL] [Abstract][Full Text] [Related]
54. Women's experiences with genomic testing for breast cancer recurrence risk.
Tzeng JP; Mayer D; Richman AR; Lipkus I; Han PK; Valle CG; Carey LA; Brewer NT
Cancer; 2010 Apr; 116(8):1992-2000. PubMed ID: 20213682
[TBL] [Abstract][Full Text] [Related]
55. Online patient education and risk assessment: project OPERA from Cancerbackup. Putting inherited breast cancer risk information into context using argumentation theory.
Mackay J; Schulz P; Rubinelli S; Pithers A
Patient Educ Couns; 2007 Aug; 67(3):261-6. PubMed ID: 17590305
[TBL] [Abstract][Full Text] [Related]
56. A role for common genomic variants in the assessment of familial breast cancer.
Sawyer S; Mitchell G; McKinley J; Chenevix-Trench G; Beesley J; Chen XQ; Bowtell D; Trainer AH; Harris M; Lindeman GJ; James PA
J Clin Oncol; 2012 Dec; 30(35):4330-6. PubMed ID: 23109704
[TBL] [Abstract][Full Text] [Related]
57. Do women understand the odds? Risk perceptions and recall of risk information in women with a family history of breast cancer.
Hopwood P; Howell A; Lalloo F; Evans G
Community Genet; 2003; 6(4):214-23. PubMed ID: 15331867
[TBL] [Abstract][Full Text] [Related]
58. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
Lerman C; Narod S; Schulman K; Hughes C; Gomez-Caminero A; Bonney G; Gold K; Trock B; Main D; Lynch J; Fulmore C; Snyder C; Lemon SJ; Conway T; Tonin P; Lenoir G; Lynch H
JAMA; 1996 Jun; 275(24):1885-92. PubMed ID: 8648868
[TBL] [Abstract][Full Text] [Related]
59. Women's experiences of undergoing BRCA1 and BRCA2 testing: organisation of the German Hereditary Breast and Ovarian Cancer Consortium Survey and Preliminary Data from Münster.
Nippert I; Schlegelberger B;
Community Genet; 2003; 6(4):249-58. PubMed ID: 15331871
[TBL] [Abstract][Full Text] [Related]
60. Cancer-related distress in unselected women with newly diagnosed breast or ovarian cancer undergoing BRCA1/2 testing without pretest genetic counseling.
Høberg-Vetti H; Eide GE; Siglen E; Listøl W; Haavind MT; Hoogerbrugge N; Bjorvatn C
Acta Oncol; 2019 Feb; 58(2):175-181. PubMed ID: 30334464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
